J&J sees 'opportunities' in neuro and immunology post-Ambrx buy fiercebiotech.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercebiotech.com Daily Mail and Mail on Sunday newspapers.
By Denny Jacob Johnson & Johnson is scheduled to report its fourth-quarter results Tuesday before the market opens. Here's what you need to know. NET.
The race for Johnson & Johnson's (NYSE: JNJ) top executive position has intensified following the unexpected exit of Ashley McEvoy, the former head of the company's medical device unit, potentially altering the anticipated succession plans within the healthcare giant